U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Sonefpeglutide
INN  
Official Name English
2-33-Glucagon-like peptide II [2-[N-[2-(1H-imidazol-4-yl)acetyl]glycine],30-L-arginine,33a-[N<sup>6</sup>-(3-hydroxypropyl)-L-lysine]] (human), 33a-ether with ?-hydro-?-hydroxypoly(oxy-1,2-ethanediyl), (33a?1) ether with immunoglobulin G4 [1-[1-(3-hydrox
Preferred Name English
glucagon-like peptide 2 (GLP-2) analogue, conjugated through a 3.4 kDa polyethylene glycol (PEG) linker (n ~ 75) to an Fc portion dimer of human immunoglobulin G4 (IgG4)
Common Name English
sonefpeglutide [INN]
Common Name English
N<sup>1.1</sup>-(3-{?-[3-({[Ala<sup>2</sup>>N-[(1H-imidazol-4-yl)acetyl]Gly1,Lys<sup>30</sup>>Arg<sup>29</sup>]glucagon like peptide 2 (2-33)-peptidyl (1-32)-L-lysine (33)}-N<sup>6.33</sup>-yl)propyl]poly(oxyethylene(3.4 kDa))-?-oxy}propyl)[immunoglobuli
Common Name English
Code System Code Type Description
INN
13024
Created by admin on Wed Apr 02 08:11:28 GMT 2025 , Edited by admin on Wed Apr 02 08:11:28 GMT 2025
PRIMARY
FDA UNII
J28M3X94LD
Created by admin on Wed Apr 02 08:11:28 GMT 2025 , Edited by admin on Wed Apr 02 08:11:28 GMT 2025
PRIMARY
SMS_ID
300000056152
Created by admin on Wed Apr 02 08:11:28 GMT 2025 , Edited by admin on Wed Apr 02 08:11:28 GMT 2025
PRIMARY
CAS
2854391-99-2
Created by admin on Wed Apr 02 08:11:28 GMT 2025 , Edited by admin on Wed Apr 02 08:11:28 GMT 2025
PRIMARY
NCI_THESAURUS
C206991
Created by admin on Wed Apr 02 08:11:28 GMT 2025 , Edited by admin on Wed Apr 02 08:11:28 GMT 2025
PRIMARY
ACTIVE MOIETY
Sonefpeglutide
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966